COUGH INDUCED BY QUINAPRIL WITH RESOLUTION AFTER CHANGING TO FOSINOPRIL

被引:14
作者
SHARIF, MN
EVANS, BL
PYLYPCHUK, GB
机构
[1] UNIV SASKATCHEWAN,DEPT INTERNAL MED,182 WALL ST,SASKATOON S7K 1N4,SK,CANADA
[2] CITY HOSP,DEPT PHARM,CLIN PHARM SERV,SASKATOON S7K 1N4,SK,CANADA
[3] ST PAULS HOSP,DEPT MED,SASKATOON S7K 1N4,SK,CANADA
关键词
D O I
10.1177/106002809402800606
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To report a case of chronic, nonproductive cough secondary to the angiotensin-converting enzyme (ACE) inhibitor quinapril, with complete resolution after switching to another ACE inhibitor, fosinopril. DATA SOURCES: All relevant articles from January 1985 through February 1993 were identified, primarily through MEDLINE search and review of pertinent articles' bibliographies. CASE SUMMARY: A 68-year-old woman developed a dry, irritating cough within one month of starting quinapril therapy for the treatment of essential hypertension. The patient was a nonsmoker with no respiratory illnesses. The cough continued for the duration of therapy with quinapril. One month after changing to fosinopril therapy, the patient reported complete resolution of the cough. She remains cough-free to date. DISCUSSION: Cough induced by ACE inhibitors is a frequently documented adverse effect. It is severe enough to require discontinuation of therapy in 1-10 percent of patients. The cough is considered to be a class-related adverse effect with cross-reactions between ACE inhibitors routinely reported. At this time, changing to another ACE inhibitor or additive therapy with nonsteroidal antiinflammatory drugs is not recommended. Discontinuation of the ACE inhibitor results in rapid alleviation of the cough, although this is not always necessary, as most patients may experience a cessation or decrease in cough. We report a case of cough following the administration of quinapril, with complete resolution after changing to the alternative ACE inhibitor fosinopril in a patient with essential hypertension. CONCLUSIONS: Cough has been encountered commonly after the administration of ACE inhibitors. Frequency of cough is variable and although this complication has been described as a class effect, patients with a persistent, severe ACE inhibitor-induced cough may benefit from a trial of fosinopril therapy. This may be particularly useful in patients unable to tolerate an alternative class of antihypertensive agents.
引用
收藏
页码:720 / 722
页数:3
相关论文
共 26 条
[1]  
BERKIN KE, 1989, EUR RESPIR J, V2, P198
[2]  
CARRUTHERS SG, 1986, CAN MED ASSOC J, V135, P217
[3]   COUGH ASSOCIATED WITH CAPTOPRIL AND ENALAPRIL [J].
COULTER, DM ;
EDWARDS, IR .
BRITISH MEDICAL JOURNAL, 1987, 294 (6586) :1521-1523
[4]   ACE INHIBITOR-INDUCED COUGH [J].
DO, TM ;
WANDRES, DL ;
HART, LL .
DICP-THE ANNALS OF PHARMACOTHERAPY, 1990, 24 (11) :1059-1060
[5]  
FOGARI R, 1992, J CARDIOVASC PHARM, V19, P670
[6]   ENALAPRIL-INDUCED COUGH [J].
GIBSON, GR .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (12) :2701-2703
[7]  
HOOD S, 1987, NEW ZEAL MED J, V100, P6
[8]   PHARMACOKINETICS OF FOSINOPRIL IN PATIENTS WITH VARIOUS DEGREES OF RENAL-FUNCTION [J].
HUI, KK ;
DUCHIN, KL ;
KRIPALANI, KJ ;
CHAN, D ;
KRAMER, PK ;
YANAGAWA, N .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (04) :457-467
[9]   COUGH AND ANGIONEUROTIC-EDEMA ASSOCIATED WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPY - A REVIEW OF THE LITERATURE AND PATHOPHYSIOLOGY [J].
ISRAILI, ZH ;
HALL, WD .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (03) :234-242
[10]  
JUST PM, 1989, PHARMACOTHERAPY, V9, P82